ABBOTT BINAXNOW™ COVID-19 Ag CARD AND NAVICA MOBILE APP
Product Description
BINAXNOW® COVID-19 Ag CARD AND NAVICA™ MOBILE APP. TAKING COVID-19 TESTING PROGRAMS TO A NEW LEVEL Available again Early May 2022.
Designed to restore confidence in daily life
The 15-minute BinaxNOW™ COVID-19 Ag Card, a rapid antigen test, was designed alongside the revolutionary NAVICA™ digital system for testing in CLIA-waived settings like hospitals, doctor offices, universities, pharmacies, long term care facilities.
This first-of-its-kind NAVICA app allows people who test negative to get a temporary digital NAVICA Pass, similar to an airline boarding pass. Organizations will be able to verify an individual's negative COVID-19 test results by scanning the individual's digital NAVICA Pass to facilitate entry into facilities, along with the vaccine, hand-washing, social distancing, enhanced cleaning, and mask-wearing.
The BinaxNOW COVID-19 Ag Card test has received U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA). 40 TESTS/KIT. Price per Kit.
A BREAKTHROUGH ANTIGEN TEST
Cost-effective, high performing test designed for decentralized testing
Visually read results in 15 minutes - no instrument required
Simple test procedure using a direct nasal swab
Onboard extraction allows the swab to be directly inserted into the test card
Room temperature storage
Emergency Use Authorization (EUA) supports testing in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
